epocrates logo
epocrates logo
epocrates logo
  • 0

Tables

epocrates logo

Sign in to access our clinical decision support tools

Sign in Create Account
Browse:
Tables

H. pylori Tx Regimens, Pediatric >35 kg

(J Pediatr Gastroenterol Nutr 2017;64:991; product info)

clarithromycin and metronidazole susceptible

[14 day regimen]
[amoxicillin 1 g PO bid OR metronidazole 500 mg PO bid] + [clarithromycin 500 mg PO bid] + [PPI PO bid (see options below)]
[10 day regimen]
[amoxicillin 1 g PO bid] + [PPI PO bid (see options below)] x5 days, then [clarithromycin 500 mg PO bid] + [metronidazole 500 mg PO bid] + [PPI PO bid (see options below)] x5 days

clarithromycin susceptible, metronidazole resistant

[14 day regimen]
[amoxicillin 1 g PO bid] + [clarithromycin 500 mg PO bid] + [PPI PO bid (see options below)] +/- [bismuth subsalicylate 262 mg PO qid (<10 yo) or 524 mg PO qid (10 yo or older)]

clarithromycin resistant, metronidazole susceptible

[14 day regimen]
[amoxicillin 1 g PO bid] + [metronidazole 500 mg PO bid] + [PPI PO bid (see options below)] +/- [bismuth subsalicylate 262 mg PO qid (<10 yo) or 524 mg PO qid (10 yo or older)]

clarithromycin and metronidazole resistant or susceptibility unknown

[14 day regimen]
[amoxicillin 1.5 g PO bid] + [metronidazole 500 mg PO bid] + [PPI PO bid (see options below)] +/- [bismuth subsalicylate 262 mg PO qid (<10 yo) or 524 mg PO qid (10 yo or older)]
[14 day regimen]
[amoxicillin 1 g PO bid] + [metronidazole 500 mg PO bid] + [clarithromycin 500 mg PO bid] + [PPI PO bid (see options below)]

PPI options

[standard doses bid]
esomeprazole 40 mg PO bid; lansoprazole 60 mg PO bid; omeprazole 40 mg PO bid; pantoprazole 80 mg PO bid; rabeprazole 40 mg PO bid
Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information